MedTrace Logo

Digitalized Exercise Fit Tool Intervention for Adolescents With Blood Cancer

NCT07621887 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2026-07-27

No results posted yet for this study

Summary

The goal of this clinical trial is to learn if a digitalised Exercise Fit Tool (EFT) mobile application can promote physical activity in adolescents aged 12-18 years who have completed treatment for hematologic cancer (e.g., leukaemia and lymphoma). The main questions it aims to answer are:

1. Is it feasible to conduct a larger randomised controlled trial of the digitalised EFT intervention?
2. Does the digitalised EFT intervention improve physical activity levels, physical activity self-efficacy, and quality of life at 6 months?

Researchers will compare the digitalised EFT intervention group to a usual care group to see if the mobile application can promote physical activity levels, physical activity self-efficacy, and quality of life in adolescents with hematologic cancer.Participants will:

1. Receive a 20-minute educational session on how to use the mobile application
2. Use the mobile application to self-assess their appropriate physical activity level and exercise with a virtual coach
3. Complete questionnaires and wear an accelerometer at 1, 3, and 6 months after enrollment
4. Attend a 20-30-minute individual interview at 6 months (intervention group only, 10 participants)

Conditions

Interventions

BEHAVIORAL

Digitalized Exercise Fit Tool Intervention

Participants in the intervention group will be delivered a 20-minute educational session to the participants. During this session, participants will be educated about the introduction and operation of the mobile application.

BEHAVIORAL

Usual Care

Participants in the control group will receive usual care with treatment and follow-ups from the hospital.

Sponsors & Collaborators

  • The Hong Kong Polytechnic University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
12 Years
Max Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-07-20
Primary Completion
2027-07-19
Completion
2027-12-31

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07621887 on ClinicalTrials.gov